Studies find no COVID benefit for preventive hydroxychloroquine or for convalescent plasma – CIDRAP

Two studies published yesterday in the New England Journal of Medicine found that two once-promising but largely discredited COVID-19 treatmentshydroxychloroquine and convalescent plasmadidn’t prevent infection or lead to clinical improvement.
‘No compelling data’
The first study, an open-label trial led by researchers at Hospital Germans Trias i Pujol in Barcelona, Spain, involved randomly assigning clusters of healthy adults with high-risk, close-contact exposure to a COVID-19 patient to either…

Click here to view the original article.